Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Hydroxychloroquine  COVID-19 treatment studies for HCQ  C19 studies: HCQ  HCQ   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
A Preventive Study on Hydroxychloroquine Prophylaxis against COVID-19 in Health Care Workers at a Tertiary Care Center in North India
Bhandari et al., International Journal of Medicine and Public Health, doi:10.5530/ijmedph.2021.1.4
Bhandari et al., A Preventive Study on Hydroxychloroquine Prophylaxis against COVID-19 in Health Care Workers at a Tertiary.., International Journal of Medicine and Public Health, doi:10.5530/ijmedph.2021.1.4
Feb 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 4,239 healthcare workers using HCQ prophylaxis showing no mortality, 8 mild symptomatic cases, and 85 asymptomatic cases, with the cases occuring mostly in the first week.
Bhandari et al., 28 Feb 2021, India, peer-reviewed, 10 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
Abstract: Int J Med. Public Health. 2021; 11(1):24-27. A Multifaceted Peer Reviewed Journal in the field of Medicine and Public Health www.ijmedph.org | www.journalonweb.com/ijmedph Original Article A Preventive Study on Hydroxychloroquine Prophylaxis against COVID-19 in Health Care Workers at a Tertiary Care Center in North India Sudhir Bhandari1, Govind Rankawat2,*, Shivam Priydarshi1, Nachiketa Vyas1, Ajeet Singh1, Raman Sharma1, Vishal Gupta1, Shrikant Sharma1, Nidhi Gupta3, Monisha Singhal3 ABSTRACT Sudhir Bhandari1, Govind Rankawat2,*, Shivam Priydarshi1, Nachiketa Vyas1, Ajeet Singh1, Raman Sharma1, Vishal Gupta1, Shrikant Sharma1, Nidhi Gupta3, Monisha Singhal3 Department of General Medicine, SMS Medical College and Attached Group of Hospital, Jaipur, Rajasthan, INDIA. 2 Department of General Medicine, SMS Medical College, Jaipur, Rajasthan, INDIA. 3 Department of Biotechnology, IIS (Deemed to be University), Mansarovar, Jaipur, INDIA. Background: The menace of COVID-19 has put a huge burden on health care system predisposing health care workers engaged in management to COVID-19 infections. The nonavailability of effective drug against COVID-19 warrants extra cover as prophylactic therapy for health care workers, especially against transmission from asymptomatic patients. Hydroxychloroquine (HCQ) for prophylaxis of COVID-19 had been advocated by some researchers. Hence, in this project, evaluation of HCQ as preventive strategy for healthcare workers against COVID-19 infection was studied. Materials and Methods: HCQ was prescribed as a prophylactic therapy as per the advisory of National Task Force of Indian Council of Medical Research, India. The data regarding consumption profile, COVID-19 infection and adverse drug reaction profile of HCQ in healthcare workers was collected. Results: Record of 4,239 health workers with hydroxychloroquine consumed was available till date. 139 subjects were dropped out of study as they did not consume the HCQ tablets. 93 heath workers (2.19%) were infected with COVID-19 infection but in early weeks of prophylactic therapy and were asymptomatic. A few of them (08 patients) had mild symptomatic manifestation with RT- PCR reported positive for SARS-CoV-2. No mortality was reported as among healthcare workers, engaged in management of COVID-19 patients at the tertiary care institute in Jaipur, India. HCQ prophylaxis in standard doses produced predominantly gastrointestinal side effects in 20 subject and headache in 10 health workers. Conclusion: The present study showed that HCQ prophylaxis is safe and effective in standard doses against COVID-19 infection. The frontline workers engaged in management of COVID-19 may be given HCQ prophylaxis as an extra cover. However, it’s broadening usage as preventive strategy, in general for people especially in cardiovascular incidences; require enhanced research and further validation. Key words: Adverse drug reaction, COVID-19, Health workers, Hydroxychloroquine, Prophylaxis. 1 Correspondence Dr. Govind Rankawat MD (General Medicine), SMS Medical College and Attached Group of Hospitals, Jaipur-302004, Rajasthan, INDIA. Mobile no: +91 8290523306 Email: govindrankawat@gmail.com History • Submission Date: 19-07-2020; • Revised Date: 18-08-2020; • Accepted Date: 24-09-2020; DOI : 10.5530/ijmedph.2021.1.4 Article Available online http://www.ijmedph.org/v11/i1 Copyright © 2021 Phcog.Net. This is an openaccess article distributed under the terms of the Creative Commons..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit